Skip to main content
HR 4841 114th Congress House Health Administrative law and regulatory procedures Department of Defense Department of Health and Human Services Department of Veterans Affairs Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Government employee pay, benefits, personnel management Health facilities and institutions Health personnel Health programs administration and funding Medical education Military medicine Prescription drugs State and local government operations Veterans' medical care

Co-Prescribing Saves Lives Act of 2016

Introduced: March 23, 2016 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 5, 2016
Referred to the Subcommittee on Military Personnel.
Mar 28, 2016
Referred to the Subcommittee on Indian, Insular and Alaska Native Affairs.
Mar 25, 2016
Referred to the Subcommittee on Health.
Mar 23, 2016
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, Veterans' Affairs, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 23, 2016
Introduced in House
 Plain-English summary Congressional Research Service

Co-Prescribing Saves Lives Act of 2016

This bill requires the Department of Health and Human Services (HHS), the Department of Veterans Affairs (VA), and the Department of Defense (DOD) to: (1) establish training guidelines for federal health care facilities and federally qualified health centers; and (2) train certain health care providers at federal health care facilities on best practices for prescribing pain medications, principles of pain management, the misuse potential of controlled substances, identification of potential substance use disorders and referral to further evaluation and treatment, and disposal of controlled substances.

HHS, the VA, and DOD must establish, for certain health care facilities, guidelines for the prescription of naloxone to individuals at an elevated risk of overdose. (Naloxone is a prescription drug used to rapidly reverse an overdose of opioids, which are drugs with effects similar to opium, such as heroin and certain pain medications.)

HHS must award grants to state departments of health for the development and application of guidelines for the prescription of opioid overdose reversal drugs and to increase access to naloxone. Grants may be used to:

  • establish a program for purchasing, prescribing, and distributing opioid overdose reversal drugs;
  • expand innovative models of naloxone distribution;
  • train and provide resources to health care providers and pharmacists on prescribing opioid overdose reversal drugs;
  • offset individuals' cost-sharing for opioid overdose reversal drugs;
  • conduct community outreach to raise awareness of the availability of opioid overdose reversal drugs; and
  • establish protocols to connect patients who have experienced a drug overdose with treatment.
What's happening now April 5, 2016

Referred to the Subcommittee on Military Personnel.

 Committees of jurisdiction 7
 Cosponsors 2
All 2 Democratic 2